CVS Health Beats EPS Estimate $2.58 vs $1.85, Raises 2026 Guidance on Insurance Recovery

According to CNBC, CVS Health on Wednesday reported second-quarter adjusted earnings per share of $2.58, beating analyst expectations of $1.85, with revenue reaching $106.10 billion versus $100.11 billion expected. The company raised its full-year 2026 guidance to $7.90–$8.10 per share adjusted profit and expects revenue of at least $414 billion, both increases from previous outlooks.

The improved outlook reflects strength across all three business segments, particularly CVS' insurance unit Aetna. Aetna's medical benefit ratio—a measure of medical expenses relative to premiums—improved to 87.4% from 89.9% year-over-year, beating the analyst consensus of 89.8%, indicating better cost management amid high medical expenses in Medicare Advantage plans.